This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2005 Oct;116(4):941-4.

doi: 10.1016/j.jaci.2005.07.021.

Immune supplementation and immune modulation with intravenous immunoglobulin

Bruce D Mazer¹, Salem Al-Tamemi, Joyce W Yu, Qutayba Hamid

Affiliations

PMID: 16210080
DOI: 10.1016/j.jaci.2005.07.021

Immune supplementation and immune modulation with intravenous immunoglobulin

Bruce D Mazer et al. J Allergy Clin Immunol. 2005 Oct.

. 2005 Oct;116(4):941-4.

doi: 10.1016/j.jaci.2005.07.021.

Authors

Bruce D Mazer¹, Salem Al-Tamemi, Joyce W Yu, Qutayba Hamid

Affiliation

¹ Meakins Christie Laboratories, McGill University, Montreal, Canada.

PMID: 16210080
DOI: 10.1016/j.jaci.2005.07.021

No abstract available

PubMed Disclaimer

Similar articles

The role of intravenous immunoglobulins in pediatric diseases.
Ramasubramanian KV, Kumar A, Kabra SK, Seth V. Ramasubramanian KV, et al. Indian Pediatr. 1999 Jan;36(1):51-63. Indian Pediatr. 1999. PMID: 10709123 Review. No abstract available.
Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
[No authors listed] [No authors listed] CMAJ. 1992 Jan 15;146(2):121-4. CMAJ. 1992. PMID: 1735037 Free PMC article. No abstract available.
Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
Zeidman LA, Fahey CD, Grinblatt DL, Harsanyi K. Zeidman LA, et al. Pediatr Neurol. 2006 Jan;34(1):60-2. doi: 10.1016/j.pediatrneurol.2005.06.012. Pediatr Neurol. 2006. PMID: 16376282
[Present status of high-dose intravenous immunoglobulin therapy and the future prospects ].
Kawasugi K. Kawasugi K. Nihon Rinsho Meneki Gakkai Kaishi. 2003 Jun;26(3):87-95. Nihon Rinsho Meneki Gakkai Kaishi. 2003. PMID: 12868126 Review. Japanese. No abstract available.
[Polyvalent immunoglobins in general pediatrics: what place, what risk, and what cost?].
Dommergues JP, Bader-Meunier B. Dommergues JP, et al. Arch Pediatr. 1999;6 Suppl 2:397s-399s. doi: 10.1016/s0929-693x(99)80480-1. Arch Pediatr. 1999. PMID: 10370548 French. No abstract available.

See all similar articles

Cited by

Combination Immunotherapy with Passive Antibody and Sulfasalazine Accelerates Fungal Clearance and Promotes the Resolution of Pneumocystis-Associated Immunopathogenesis.
Hoy Z, Wright TW, Elliott M, Malone J, Bhagwat S, Wang J, Gigliotti F. Hoy Z, et al. Infect Immun. 2020 Jan 22;88(2):e00640-19. doi: 10.1128/IAI.00640-19. Print 2020 Jan 22. Infect Immun. 2020. PMID: 31611280 Free PMC article.
Tregitope peptides: the active pharmaceutical ingredient of IVIG?
De Groot AS, Cousens L, Mingozzi F, Martin W. De Groot AS, et al. Clin Dev Immunol. 2013;2013:493138. doi: 10.1155/2013/493138. Epub 2013 Dec 25. Clin Dev Immunol. 2013. PMID: 24454476 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.